1427329-27-8 Usage
General Description
The chemical (3-hydroxy-3-methyl-cyclobutyl)-carbamic acid tert-butyl ester is an organic compound with a molecular formula of C9H17NO3. It is a carbamate ester, which is a type of chemical compound commonly used as a pesticide or herbicide. This particular compound has a tert-butyl ester group, which is a common functional group used in organic chemistry. It is likely used as an intermediate in the synthesis of other compounds or as a reagent in organic reactions. The compound's cyclobutyl and hydroxy-methyl groups may contribute to its reactivity and potential biological activity. Overall, (3-hydroxy-3-methyl-cyclobutyl)-carbamic acid tert-butyl ester is a versatile organic compound with potential uses in various chemical and industrial processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1427329-27-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,7,3,2 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1427329-27:
(9*1)+(8*4)+(7*2)+(6*7)+(5*3)+(4*2)+(3*9)+(2*2)+(1*7)=158
158 % 10 = 8
So 1427329-27-8 is a valid CAS Registry Number.
1427329-27-8Relevant articles and documents
1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS
-
, (2018/04/27)
A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
